title: Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy.
abstract: Tumor heterogeneity impinges on prognosis, response to therapy, and metastasis. As such, heterogeneity is one of the most important and clinically relevant areas of cancer research. Breast cancer displays frequent intra- and inter-tumor heterogeneity as the result of genetic and non-genetic alterations that often enhance the vigor of cancer cells. In-depth characterization and understanding of the origin of this phenotypic and molecular diversity is paramount to improving diagnosis, the definition of prognostic and predictive biomarkers, and the design of therapeutic strategies. Here, we summarize current knowledge about sources of breast cancer heterogeneity, its consequences, and possible counter-measures. We discuss especially the impact on tumor heterogeneity of the differentiation state of the cell-of-origin, cancer cell plasticity, the microenvironment, and genetic evolution. Factors that enhance cancer cell vigor are clearly detrimental for patients.
authors.affiliation: Friedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.
authors.forename: Shany
authors.initials: S
authors.lastname: Koren
authors.affiliation: Friedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland. Electronic address: bentires@fmi.ch.
authors.forename: Mohamed
authors.initials: M
authors.lastname: Bentires-Alj
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D000066670:Cell Plasticity; D005260:Female; D018740:Genetic Heterogeneity; D006801:Humans; D014411:Neoplastic Stem Cells / Q000473:pathology*; D059016:Tumor Microenvironment